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Abstract
A recent study using cell-based assays together with an olfactory psychophysical survey in humans
has established a link between a genetic polymorphism in an odorant receptor and variability in
perception of the smell of the steroid androstenone.
Published: 26 November 2007
Genome Biology 2007, 8:230 (doi:10.1186/gb-2007-8-11-230)
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2007/8/11/230
© 2007 BioMed Central Ltd 
Different people have different noses. Not just on the
outside, it turns out, but inside as well. Indeed, there may be
more variation in olfactory abilities among humans than in
any other sense. We have all had the experience of being in a
room where everyone seems to smell some odor, good or
bad, that we simply do not perceive, no matter how much we
sniff. Detection thresholds - the ability to detect a given odor
at a particular concentration - vary over several orders of
magnitude of concentration in different people. There are
also many cases of selective anosmia, the inability to detect a
particular odor, in the human (and mouse) population, and
many of these seem to sort along genetic lines. One of the
best known is a selective anosmia to isovaleric acid. This is
socially important because isovaleric acid is the main
noxious component of body odor. About 6% of the human
population appears to have this anosmia, and they tend to
self identify [1].
The high level of variation in the sense of smell may be
related to the large family of genes that encode the odor
receptors. Odor receptors are G-protein-coupled receptors
that are expressed in specialized cilia on the tips of
olfactory sensory neurons located in a layer of epithelium
at the back of the nasal cavity. The odor receptor genes
were first identified in 1991 by Linda Buck and Richard
Axel [2], who predicted that they might comprise a very
large gene family. We now know that they form the largest
gene family known in mammals, numbering more than
1,000 genes [3], or more than 5% of the typical
mammalian genome. Even humans, whose sense of smell
is thought to be less good than that of many other animals,
have some 350 odor receptor genes, comprising more than
1% of the coding genome [4]. For comparison, the next
largest family of GPCRs is that of the serotonin receptors,
with just 15 members. Given all the genetic material in the
odor receptor genes, there are presumably many
opportunities for polymorphisms and other variations
with phenotypic effects.
A recent report in Nature by Keller et al. [5] now establishes a
specific connection between a particular genetic poly-
morphism and olfactory ability in humans - in this case, the
detection of the steroids androstenone and androstadienone.
This work makes use of two different and complementary
techniques: functional assays in cells containing introduced
receptor genes and a psychophysical survey of human
subjects. The extensive genetic mapping information in
human populations and the fact that humans can report their
olfactory experiences makes for a powerful collaboration.
Androstenone is well established as a pheromone in pigs; it
is also found in truffles and accounts for the ability of boars
to sniff them out. Androstenone and the closely related
steroid androstadienone have been suggested, though never
proven, to act as pheromones in humans. Different people
report a wide range of perceived odors from these chemicals,
from unpleasant and urinous to sweaty, woody or even
pleasantly floral, and nearly 30% of the human population
claims not to be able to smell them at all [6,7]. These two
chemicals therefore represent an interesting example of
genetic variation in the human population, and one that is
relatively easy to document.There are numerous possible causes for differential olfactory
abilities, including age, gender, environment, health status
and experience. Between the receptor and the change in
membrane voltage that signals the presence of an odor to the
brain lies a complex biochemical pathway, and mutations in
any of the proteins in this pathway can also result in olfactory
abnormalities. An example is Kallmann syndrome [8], which
is caused by mutation of a G protein that happens to be
expressed in olfactory neurons as well as in other tissues.
Along with hypogonadism, caused by a deficiency in pituitary
hormones, patients with this condition also have anosmia.
The 350 or so genes for odor receptors would, however, seem
to be the most likely targets for mutations affecting olfaction.
Single-nucleotide polymorphisms (SNPs) occur at consider-
able frequency in the human genome and are thought to
constitute the genetic basis for most of the variability in
human traits. SNPs that modify a particular odor receptor
could lead to significant differences in threshold sensitivity
towards particular odorants or to odorant-specific olfactory
deficits. The most obvious candidates for generating a
functional effect are the 600 or so non-synonymous SNPs that
change amino-acid residues that might be crucial to protein
function of odorant receptors [9]. In addition, polymorphisms
in the promoter or other regulatory regions of odor receptor
genes might result in altered expression patterns that modify
olfactory function [10].
There is an enormous diversity in the repertoire of
functional odorant receptor genes among different people.
Roughly 60% of human odor receptor genes have mutated
into non-functional pseudogenes in a relatively recent
genomic process; thus a substantial fraction of human odor
receptors might be expected to segregate between an intact
and a pseudogene form in different individuals. Menashe et
al. [11] genotyped 51 odor receptor loci in 189 individuals of
several ethnic origins to screen for SNPs that distinguish the
intact and pseudogenic forms. Remarkably, of the 189
individuals, 178 functionally different genomes were found.
These and earlier findings suggest that differing evolutionary
pressures may have shaped the chemosensory repertoire in
different human populations. Additional variation in the
population may come from differences in gene expression.
Experiments with custom microarrays specialized for
detecting odor receptor genes have found that the expressed
receptor repertoires of any pair of individuals differ by at
least 14% [12], suggesting that polymorphisms exist not only
in coding regions but also in promoter and other regulatory
regions (Figure 1).
Despite many anecdotal reports and numerous population
screens that indicate heritable olfactory traits, a definitive
connection has never been made between single-gene
mutations and olfactory abilities. Now combined work
from two laboratories [5], those of Leslie Voshall at
Rockefeller University, New York, and Hiro Matsunami at
Duke University School of Medicine in Durham, North
Carolina, provides this evidence. This study combined a cell-
based assay technique to identify ligands for human odor
receptors with an olfactory psychophysical study of a diverse
population of human volunteers. The authors cloned a panel
of 335 putative human odor receptors and expressed them in
Hana3A cells, which were then screened for androstenone-
mediated stimulation. A receptor called OR7D4 gave the
strongest response, suggesting that this is the high-affinity
androstenone receptor in humans. Polymorphisms in
OR7D4 were then identified in 391 individuals and two non-
synonymous substitutions that occurred at the highest
frequency were identified. These substitutions gave two
receptor variants of OR7D4, called RT and WM, which
differed in one amino acid. The authors investigated the
ligand specificity of the two variants in the cell-based assay
and found that the RT form responded to androstadienone
whereas the WM form did not.
To correlate this variation in OR7D4 with variation in the
actual perception of androstenone and androstadienone,
olfactory psychophysical studies were carried out with 391
human volunteers. Subjects were asked to rate the perceived
intensity, valence (the emotional reaction associated with a
stimulus) and detection threshold of androstenone and
androstadienone, compared with control odors. Statistical
analysis showed that the OR7D4 genotype had a significant
effect on the perception of androstenone odor intensity.
Heterozygous RT/WM individuals as a group had higher
detection thresholds than RT/RT individuals, that is, they
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Figure 1
The diversity of odor receptor gene expression in humans. The numbers
refer to the number of genes whose expression was detected (at
P< 0.05) in one or more of three samples of olfactory epithelium [12]. As
can be seen, there is a substantial difference in the odor gene repertoire
expressed in the three samples.
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OE3were less sensitive to the odor. Variation in OR7D4 genotype
also affected the perception of odor quality. The RT/WM
group rated the smell of both androstenone and
androstadienone as less unpleasant than did the RT/RT
group. In this study, non-parametric regression analysis
showed that OR7D4 genotype explained 19% and 39% of the
variance in the valence and intensity rating, respectively, of
the steroid odors. Thus, although there must be some
additional receptors or non-genetic effects involved, OR7D4
genotype was clearly identified as a significant heritable
factor influencing the perception of androstenone and
androstadienone. This study provides the first link between
an identified genetic polymorphism in an odor receptor gene
and altered perception of an odor compound.
GPCRs are estimated to account for some 50% of the targets
for drugs in current use. As the odor receptors are GPCRs,
the demonstration of polymorphic variation in their function
by Keller et al. [5] provides strong support for the likelihood
that polymorphic variation in other GPCRs has important
effects on drug efficacy and side effects. Non-synonymous
SNPs in GPCRs can clearly have large effects on function,
and further investigation of the odor receptors is likely to
unearth more information on variation and its effect on
function in this important receptor class.
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